Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Blood and Lymphatic Cancer: Targets and Therapy
List of Issues
Volume 4, Issue

Blood and Lymphatic Cancer: Targets and Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Current issue
All volumes & issues
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Cover image for Blood and Lymphatic Cancer: Targets and Therapy, Volume 4, 2014

Blood and Lymphatic Cancer: Targets and Therapy, Volume 4, Issue (2014)

Browse this journal

Current issue
List of issues
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Blood and Lymphatic Cancer: Targets and Therapy, Volume 4, Issue (2014)

See all volumes and issues

Vol 14, 2024 Vol 13, 2023 Vol 12, 2022 Vol 11, 2021 Vol 10, 2020 Vol 9, 2019 Vol 8, 2018 Vol 7, 2017 Vol 6, 2016 Vol 5, 2015 Volume 4, 2014 Vol 3, 2013 Vol 2, 2012 Vol 1, 2011

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia

Xavier Thomas

Pages: 1-8

Published online: 17 Apr 2014

AbstractforProfile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia | Full Text | References | PDF (326.3 KB)

115 Views
2 CrossRef citations
0Altmetric

Open Access

Review Article

Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options

Zahra Mozaheb

Pages: 9-14

Published online: 19 May 2014

AbstractforTreating the elderly patient with chronic lymphocytic leukemia: current and emerging options | Full Text | References | PDF (209.9 KB)

81 Views
1 CrossRef citations
0Altmetric

Open Access

Review Article

Profile of elotuzumab and its potential in the treatment of multiple myeloma

Yi-Chang Liu, Susann Szmania & Frits van Rhee

Pages: 15-27

Published online: 03 Jun 2014

AbstractforProfile of elotuzumab and its potential in the treatment of multiple myeloma | Full Text | References | PDF (835.4 KB)

134 Views
7 CrossRef citations
0Altmetric

Open Access

Review Article

Splenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management

Larissa Sena Teixeira Mendes, Ming-Qing Du, Estella Matutes & Andrew Wotherspoon

Pages: 29-38

Published online: 23 Feb 2023

AbstractforSplenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management | Full Text | References | PDF (1.6 MB)

131 Views
1 CrossRef citations
0Altmetric

Open Access

Original Research

Article

The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use

Gregory P Kaufman, Kay M Ristow, Svetomir N Markovic & Luis F Porrata

Pages: 39-44

Published online: 23 Jul 2014

AbstractforThe absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use | Full Text | References | PDF (516.4 KB)

84 Views
0 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma

Matthew S McKinney & Anne W Beaven

Pages: 45-59

Published online: 16 Aug 2014

AbstractforYttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma | Full Text | References | PDF (334.9 KB)

109 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia

Stephen Harnicar & Sherry Mathew

Pages: 61-67

Published online: 21 Aug 2014

AbstractforSpotlight on nilotinib in the treatment of chronic myelogenous leukemia | Full Text | References | PDF (208.3 KB)

76 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase

Francesca Farina, Alessandra Stasia & Carlo Gambacorti-Passerini

Pages: 69-79

Published online: 21 Aug 2014

AbstractforDevelopments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase | Full Text | References | PDF (278.8 KB)

94 Views
2 CrossRef citations
0Altmetric

Open Access

Review Article

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib

Khalid Shoumariyeh & Nikolas von Bubnoff

Pages: 81-89

Published online: 18 Sep 2014

AbstractforLong-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib | Full Text | References | PDF (262.1 KB)

88 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources

Ann M Moormann, Jodi L Skiles, Juliana A Otieno, Geoffrey C Buckle & Terry A Vik

Pages: 91-99

Published online: 23 Sep 2014

AbstractforOptimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources | Full Text | References | PDF (243.2 KB)

107 Views
7 CrossRef citations
0Altmetric

Open Access

Review Article

Coexistence of primary myelofibrosis and chronic lymphocytic leukemia

Sonja Burgstaller & Josef Thaler

Pages: 101-105

Published online: 03 Oct 2014

AbstractforCoexistence of primary myelofibrosis and chronic lymphocytic leukemia | Full Text | References | PDF (167.2 KB)

74 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

B-cell malignancies: capture-sequencing strategies for identification of gene rearrangements and translocations into immunoglobulin gene loci

Eileen M Boyle, Brian A Walker, Christopher P Wardell, Xavier Leleu, Faith E Davies & Gareth J Morgan

Pages: 107-119

Published online: 30 Oct 2014

AbstractforB-cell malignancies: capture-sequencing strategies for identification of gene rearrangements and translocations into immunoglobulin gene loci | Full Text | References | PDF (676.3 KB)

87 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Multiple myeloma: optimal management and long-term disease control

P Sriskandarajah & FE Davies

Pages: 121-134

Published online: 06 Nov 2014

AbstractforMultiple myeloma: optimal management and long-term disease control | Full Text | References | PDF (498.9 KB)

84 Views
0 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment

Yingzi Zhang et al.

Article | Published online: 2 Jul 2024

Open Access

Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis

Nan Mei et al.

Article | Published online: 4 Jun 2024

Open Access

AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B

Jie Zhang et al.

Article | Published online: 24 Mar 2024

Open Access

Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies

Francesco Malfona et al.

Review | Published online: 13 Mar 2024

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Blood and Lymphatic Cancer: Targets and Therapy (Vol.4, Iss., 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?